Author:
van Dongen J J M, ,Lhermitte L,Böttcher S,Almeida J,van der Velden V H J,Flores-Montero J,Rawstron A,Asnafi V,Lécrevisse Q,Lucio P,Mejstrikova E,Szczepański T,Kalina T,de Tute R,Brüggemann M,Sedek L,Cullen M,Langerak A W,Mendonça A,Macintyre E,Martin-Ayuso M,Hrusak O,Vidriales M B,Orfao A
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference297 articles.
1. Foon KA, Todd RF . Immunologic classification of leukemia and lymphoma. Blood 1986; 68: 1–31.
2. van Dongen JJ, Adriaansen HJ, Hooijkaas H . Immunophenotyping of leukaemias and non-Hodgkin's lymphomas. Immunological markers and their CD codes. Neth J Med 1988; 33: 298–314.
3. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 4th edn. International Agency for Research on Cancer: Lyon, 2008; pp 439.
4. Macedo A, Orfao A, Vidriales MB, Lopez-Berges MC, Valverde B, Gonzalez M et al. Characterization of aberrant phenotypes in acute myeloblastic leukemia. Ann Hematol 1995; 70: 189–194.
5. Lucio P, Parreira A, van den Beemd MW, van Lochem EG, van Wering ER, Baars E et al. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL. Leukemia 1999; 13: 419–427.